Creative Biolabs-Immuno-oncology

Anti-DLG1 (clone RPI1G9Q7J.4I) SynExpress T7-G-I10-E Modified CD8+ T cells (CAT#: ITS-1224-CR2092)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLG1 (clone RPI1G9Q7J.4I). We employs the HBV (T7-GFP-IL-10-EcoRI) vector components and the SynExpress system of the Introns Substitution/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
DLG1
Clone
RPI1G9Q7J.4I
Species Reactivity
Rat
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
T7
Effector Gene
IL-10
Insertion Sites
EcoRI
Gene Modification
Substitution
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.89
Cell Culture
Aseptic Culture
Case Studies
Loading case studies...
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.